Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice
- 30 June 2006
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 186 (2), 402-410
- https://doi.org/10.1016/j.atherosclerosis.2005.08.009
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Regulation of Superoxide Anion Production by NADPH Oxidase in Monocytes/MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol dietJournal of Hypertension, 2003
- Superoxide Production and Expression of Nox Family Proteins in Human AtherosclerosisCirculation, 2002
- Angiotensin II-induced superoxide anion generation in human vascular endothelial cells Role of membrane-bound NADH-/NADPH-oxidasesCardiovascular Research, 1999
- An endothelial receptor for oxidized low-density lipoproteinNature, 1997
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.JCI Insight, 1996
- Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.JCI Insight, 1996
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.JCI Insight, 1996
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976